BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND ABCG2, ABC15, ABCP, BCRP, BCRP1, BMDP, CD338, CDw338, EST157481, GOUT1, MRX, MXR, MXR-1, MXR1, UAQTL1 AND Treatment
44 results:

  • 1. Constitutively Synergistic Multiagent Drug Formulations Targeting MERTK, FLT3, and BCL-2 for treatment of AML.
    Kelvin JM; Jain J; Thapa A; Qui M; Birnbaum LA; Moore SG; Zecca H; Summers RJ; Switchenko JM; Costanza E; Uricoli B; Wang X; Jui NT; Fu H; Du Y; DeRyckere D; Graham DK; Dreaden EC
    Pharm Res; 2023 Sep; 40(9):2133-2146. PubMed ID: 37704893
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Pharmacogenetics of the Primary and Metastatic Osteosarcoma: Gene Expression Profile Associated with Outcome.
    Trujillo-Paolillo A; Tesser-Gamba F; Seixas Alves MT; Filho RJG; Oliveira R; Petrilli AS; Toledo SRC
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982681
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Curcumol Synergizes with Cisplatin in Osteosarcoma by Inhibiting M2-like Polarization of Tumor-Associated Macrophages.
    Wang J; Jin J; Chen T; Zhou Q
    Molecules; 2022 Jul; 27(14):. PubMed ID: 35889217
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Cold atmospheric plasma enhances doxorubicin selectivity in metastasic bone cancer.
    Mateu-Sanz M; Ginebra MP; Tornín J; Canal C
    Free Radic Biol Med; 2022 Aug; 189():32-41. PubMed ID: 35843475
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Surface osteosarcoma: Predictors of outcomes.
    Lee SJ; Lans J; Cook SD; Chebib I; Schwab JH; Raskin KA; Lozano-Calderón S
    J Surg Oncol; 2021 Sep; 124(4):646-654. PubMed ID: 34043244
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Polymorphism of
    Yang Y; Jia J; Sun Z; Liu C; Li Z; Xiao Y; Yu J; Du F; Shi Y; Sun J; Shui J; Zhang X
    Future Oncol; 2021 Jun; 17(18):2351-2363. PubMed ID: 33709789
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. High expression of abcg2 is associated with chemotherapy resistance of osteosarcoma.
    Shu H; Yuan B; Huang Y; Wang L; He B; Sun Q; Sun L
    J Orthop Surg Res; 2021 Jan; 16(1):85. PubMed ID: 33509236
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Association between end-induction response according to the revised International Neuroblastoma Response Criteria (INRC) and outcome in high-risk neuroblastoma patients.
    Barr EK; Laurie K; Wroblewski K; Applebaum MA; Cohn SL
    Pediatr Blood Cancer; 2020 Oct; 67(10):e28390. PubMed ID: 32710697
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Serum-derived factors of breast cancer patients with brain metastases alter permeability of a human blood-brain barrier model.
    Curtaz CJ; Schmitt C; Herbert SL; Feldheim J; Schlegel N; Gosselet F; Hagemann C; Roewer N; Meybohm P; Wöckel A; Burek M
    Fluids Barriers CNS; 2020 Apr; 17(1):31. PubMed ID: 32321535
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Suppressing STAT5 signaling affects osteosarcoma growth and stemness.
    Subramaniam D; Angulo P; Ponnurangam S; Dandawate P; Ramamoorthy P; Srinivasan P; Iwakuma T; Weir SJ; Chastain K; Anant S
    Cell Death Dis; 2020 Feb; 11(2):149. PubMed ID: 32094348
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Targeting on glycosylation of mutant FLT3 in acute myeloid leukemia.
    Hu X; Chen F
    Hematology; 2019 Dec; 24(1):651-660. PubMed ID: 31533545
    [No Abstract]    [Full Text] [Related]  

  • 12. The role of TNF-α in chordoma progression and inflammatory pathways.
    Gulluoglu S; Tuysuz EC; Sahin M; Yaltirik CK; Kuskucu A; Ozkan F; Dalan AB; Sahin F; Ture U; Bayrak OF
    Cell Oncol (Dordr); 2019 Oct; 42(5):663-677. PubMed ID: 31175552
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Inherited variation in the xenobiotic transporter pathway and survival of multiple myeloma patients.
    Macauda A; Castelli E; Buda G; Pelosini M; Butrym A; Watek M; Kruszewski M; Vangsted AJ; Rymko M; Jamroziak K; Abildgaard N; Haastrup EK; Mazur G; Ríos R; Jurczyszyn A; Zawirska D; Dudziński M; Raźny M; Dutka M; Tomczak W; Suska A; Druzd-Sitek A; Marques H; Petrini M; Markiewicz M; Martinez-Lopez J; Ebbesen LH; Iskierka-Jażdżewska E; Sainz J; Canzian F; Campa D
    Br J Haematol; 2018 Nov; 183(3):375-384. PubMed ID: 30079960
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Correlation of IGF1R expression with abcg2 and CD44 expressions in human osteosarcoma.
    Kim CK; Oh S; Kim SJ; Leem SH; Heo J; Chung SH
    Genes Genomics; 2018 Apr; 40(4):381-388. PubMed ID: 29892839
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Activation of AhR with nuclear IKKα regulates cancer stem-like properties in the occurrence of radioresistance.
    Yan B; Liu S; Shi Y; Liu N; Chen L; Wang X; Xiao D; Liu X; Mao C; Jiang Y; Lai W; Xin X; Tang CE; Luo D; Tan T; Jia J; Liu Y; Yang R; Huang J; Zhou H; Cheng Y; Cao Y; Yu W; Muegge K; Tao Y
    Cell Death Dis; 2018 May; 9(5):490. PubMed ID: 29706625
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Mesenchymal stem cells: A double-edged sword in radiation-induced lung injury.
    Yao Y; Zheng Z; Song Q
    Thorac Cancer; 2018 Feb; 9(2):208-217. PubMed ID: 29235254
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Pharmacogenetic analysis of high-dose methotrexate treatment in children with osteosarcoma.
    Hegyi M; Arany A; Semsei AF; Csordas K; Eipel O; Gezsi A; Kutszegi N; Csoka M; Muller J; Erdelyi DJ; Antal P; Szalai C; Kovacs GT
    Oncotarget; 2017 Feb; 8(6):9388-9398. PubMed ID: 27566582
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. RANK-RANKL interactions are involved in cell adhesion-mediated drug resistance in multiple myeloma cell lines.
    Tsubaki M; Takeda T; Yoshizumi M; Ueda E; Itoh T; Imano M; Satou T; Nishida S
    Tumour Biol; 2016 Jul; 37(7):9099-110. PubMed ID: 26762414
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. bone morphogenetic protein 7 sensitizes O6-methylguanine methyltransferase expressing-glioblastoma stem cells to clinically relevant dose of temozolomide.
    Tso JL; Yang S; Menjivar JC; Yamada K; Zhang Y; Hong I; Bui Y; Stream A; McBride WH; Liau LM; Nelson SF; Cloughesy TF; Yong WH; Lai A; Tso CL
    Mol Cancer; 2015 Nov; 14():189. PubMed ID: 26546412
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. ILs-3, 6 and 11 increase, but ILs-10 and 24 decrease stemness of human prostate cancer cells in vitro.
    Yu D; Zhong Y; Li X; Li Y; Li X; Cao J; Fan H; Yuan Y; Ji Z; Qiao B; Wen JG; Zhang M; Kvalheim G; Nesland JM; Suo Z
    Oncotarget; 2015 Dec; 6(40):42687-703. PubMed ID: 26528857
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.